about
STAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapyThe Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal FoldA novel requirement for Janus kinases as mediators of drug resistance induced by fibroblast growth factor-2 in human cancer cellsMultifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signalingInduction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP)Jak3-independent trafficking of the common gamma chain receptor subunit: chaperone function of Jaks revisited.Hepcidin expression in human airway epithelial cells is regulated by interferon-γ.Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.Regulation of ABCA1 functions by signaling pathwaysSerum cytokine profiling analysis for zheng differentiation in chronic hepatitis B.Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy.Non-Canonical Role of IKKα in the Regulation of STAT1 Phosphorylation in Antiviral Signaling.Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein.Hyaluronan-mediated leukocyte adhesion and dextran sulfate sodium-induced colitis are attenuated in the absence of signal transducer and activator of transcription 1.Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.Signalling pathways in alcohol-induced liver inflammation.IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.Beyond 'furballs' and 'dumpling soups' - towards a molecular architecture of signaling complexes and networks.A Systems Biology Approach to Understanding Alcoholic Liver Disease Molecular Mechanism: The Development of Static and Dynamic Models.Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model.The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer.Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3.Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5.Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein.Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol.Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptorsA method for the generation of standardized qualitative dynamical systems of regulatory networks.Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells.Variable Resistance of RMS to Interferon γ SignalingStochastic simulation of signal transduction: impact of the cellular architecture on diffusion.Expression of excess receptors and negative feedback control of signal pathways are required for rapid activation and prompt cessation of signal transduction.A virtual culture of CD4+ T lymphocytes.JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.Interleukin-6 and Interferon-α Signaling via JAK1-STAT Differentially Regulate Oncolytic versus Cytoprotective Antiviral States.
P2860
Q27003190-2131E53C-AA3A-47AE-A3D1-17A7372AA164Q27677595-FCF79F82-DC6B-405E-AC8B-13B40A2D9272Q28478203-2DE488A0-903B-479E-9474-3C3A1BCC283BQ28741023-52080A2A-49F9-4D4A-A147-80230848954EQ33257134-B6378D69-7CEF-4D53-A1BE-382DC89892FAQ34181570-20A5958E-A554-414B-B08D-A4D94C34C33EQ35179041-D4B666E1-42B7-4243-ABBE-D2A85C1E4FC7Q35376317-5A101194-00F3-4300-9EF9-27F24E88DBF8Q35626943-9E58578E-0B63-4B1A-8445-D336819398C9Q35997267-4235EF2D-156C-489D-9CCC-08B3FD99D09DQ36158713-B7967228-E67F-4739-B7D8-CF7662BC9DE7Q36228458-974FC482-A9D1-4B3D-BBA0-D0F6B7998DB0Q36403135-33ECDFBE-44CA-4716-9881-B529AA24C836Q36943062-C6108D99-5B73-4BD2-A307-2F397E0DA8F4Q37377109-81924ED5-DBDE-40AC-A92C-9FEB36A9B43DQ37461766-CD77D27E-B64D-4E9F-A29D-FF8C2DCEDC49Q37532498-68AFD721-01A7-4638-A642-5A31994AB3BFQ37610453-99C86E16-B220-4611-8203-88C393C73707Q38019703-FE1376BE-628C-4772-9C45-C6884DAFF1E6Q38604295-670A9CBF-6F02-4CE4-AA77-5A39F73F23E4Q38964255-4FEC938B-61CA-4F5C-A448-28CEE94F14BDQ39401758-3691D64C-0D85-41FB-BC2F-1712533B91D8Q40128654-AE82CD79-58ED-4DA5-A35A-06379EE0E19BQ40196866-E31926EE-E7B3-4D02-B569-361329C94123Q40277634-17690F9C-59BC-4E13-BF26-92F53663EC6EQ40608592-14016D8A-8EC2-4454-8D09-900053662464Q41668344-FCF685F9-3FE5-4CC4-BBB4-1334F5466778Q41968701-8A9A4340-2F9B-4E52-A77E-4FF0178FBFB7Q42028266-5F35E69D-C3D3-4D33-9A28-386BC6A24A5FQ42093148-8D9B366B-5AB0-480A-8853-6C1A11CA1B10Q42536834-06E6B4E7-4936-4548-B6AF-D5E99F05D0A6Q43148247-9728A80D-6D98-49A6-9A14-E7349FDE70BCQ44158836-8DF49BB5-E297-44A1-8B1E-735E73429DCCQ45113852-E4212C07-662F-4BCD-A57A-4BDA2F6B4839Q49210539-C13A42A3-34ED-475C-9D2F-CF69F3EB136F
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Of JAKs, STATs, blind watchmakers, jeeps and trains.
@ast
Of JAKs, STATs, blind watchmakers, jeeps and trains.
@en
type
label
Of JAKs, STATs, blind watchmakers, jeeps and trains.
@ast
Of JAKs, STATs, blind watchmakers, jeeps and trains.
@en
prefLabel
Of JAKs, STATs, blind watchmakers, jeeps and trains.
@ast
Of JAKs, STATs, blind watchmakers, jeeps and trains.
@en
P2860
P1433
P1476
Of JAKs, STATs, blind watchmakers, jeeps and trains.
@en
P2093
Björn F Lillemeier
Ian M Kerr
P2860
P356
10.1016/S0014-5793(03)00411-3
P407
P577
2003-07-01T00:00:00Z